319
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Cytotoxicity and Oxidative Stress Induced by the Glyceraldehyde-related Maillard Reaction Products for HL-60 Cells

, , &
Pages 333-340 | Received 06 Aug 2003, Accepted 20 Oct 2003, Published online: 22 May 2014

  • 1) Kato, H., and Hayase, F., Post-translational modification of proteins by advanced amino-carbonyl reaction. In “The Post-translational Modification of Proteins”, eds. Tuboi, S., Taniguchi, N., and Katunuma, N., Japan Scientific Societies Press & CRC Press, pp. 237–251 (1992).
  • 2) Ulrich, P., and Cerami, A., Protein glycation, diabetes, and aging. Recent Prog. Horm. Res., 56, 1–21 (2001).
  • 3) Hayase, F., Recent development in the research on Maillard reaction. Recent Res. Devel. in Agricultural & Biological Chem., 1, 351–362 (1997).
  • 4) Hayase, F., Recent development of 3-deoxyosone related Maillard reaction products. Food Sci. Technol. Res., 6, 79–86 (2000).
  • 5) Degenhardt, T. P., Thorpe, S. R., and Baynes, J. W., Chemical modification of proteins by methylglyoxal. Cell. Mol. Biol., 44, 1139–1145 (1998).
  • 6) Hayase, F., Nagaraj, R. H., Miyata, S., Njoroge, F. G., and Monnier, V. M., Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem., 264, 3758–3764 (1989).
  • 7) Hayase, F., Hinuma, H., Asano, M., Kato, H., and Arai, S., Identification of novel fluorescent pyrrolopyridinium compound formed from Maillard reaction of 3-deoxyglucosone and butylamine. Biosci. Biotechnol. Biochem., 58, 1936–1937 (1994).
  • 8) Hayase, F., Konishi, Y., and Kato, H., Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci. Biotechnol. Biochem., 59, 1407–1411 (1995).
  • 9) Obayashi, H., Nakano, K., Shigeta, H., Yamaguchi, M., Yoshimori, K., Fukui, M., Fujii, M., Kitagawa, Y., Nakamura, N., Nakamura, K., Nakazawa, Y., Ienaga, K., Ohta, M., Nishimura, M., Fukui, I., and Kondo, M., Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem. Biophys. Res. Commun., 226, 37–41 (1996).
  • 10) Ahmed, M. U., Brinkmann, E., Degenhardt, T. P., Thorpe, S. R., and Baynes, J. W., Nε-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem. J., 324, 565–570 (1995).
  • 11) Shipanova, I. N., Glomb, M. A., and Nagaraj, R. H., Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys., 344, 29–36 (1997).
  • 12) Uchida, K., Khor, O. T., Oya, T., Osawa, T., Yasuda, Y., and Miyata, T., Protein modification by a Maillard reaction intermediate methylglyoxal. Immunochemical detection of fluorescent 5-methylimidazolone derivatives in vivo. FEBS Lett., 410, 313–318 (1997).
  • 13) Frye, E. B., Degenhardt, T. P., Thorpe, S. R., and Baynes, J. W., Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J. Biol. Chem., 273, 18714–18719 (1998).
  • 14) Ahmed, M. U., Brinkmann, F. E., Degenhardt, T. P., Thorpe, S. R., and Baynes, J. W., Nε-(carboxymethyl)lysine, a product of the chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem. J., 324, 565–570 (1997).
  • 15) Sell, D. R., and Monnier, V. M., Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem., 264, 21597–21602 (1989).
  • 16) Lehmann, R., and Schleicher, E. D., Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta, 297, 135–144 (2000).
  • 17) Finch, C. E., and Cohen, D. M., Aging, metabolism, and alzheimer disease — review and hypotheses. Exp. Neurol., 143, 82–102 (1997).
  • 18) Loske, C., Neumann, A., Cunningham, A. M., Nichol, K., Schinzel, R., Riederer, P., and Munch, G., Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural Transm., 105, 1005–1015 (1998).
  • 19) Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., Wakayama, I., Yanagihara, R., Garruto, R., Amano, N., and Makita, Z., Advanced glycation end products in alzheimer’s disease and other neurodegenerative diseases. Am. J. Pathol., 153, 1149–1155 (1998).
  • 20) Castellani, R., Smith, M. A., Richey, P. J., and Petty, G., Glycoxidation and oxidative stress in parkinson disease and diffuse lewy body disease. Brain Res., 737, 195–200 (1996).
  • 21) Chou, S. M., Wang, H. S., Taniguchi, A., and Bucala, R., Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyofrophic lateral sclerosis. Mol. Med., 4, 324–332 (1998).
  • 22) Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., and Makita, Z., Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J. Neuropathol. Exp. Neurol., 59, 1094–1105 (2000).
  • 23) Yamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., and Makita, Z., Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured mesangial cells. J. Biol. Chem., 277, 20309–20315 (2002).
  • 24) Yamagishi, S., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., and Makita, Z., Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem. Biophys. Res. Commun., 290, 973–978 (2002).
  • 25) Usui, T., and Hayase, F., Isolation and identification of the 3-hydroxy-5-hydroxymethyl-pyridinium compound as a novel advanced glycation end product on glyceraldehyde-related Maillard reaction. Biosci. Biotechnol. Biochem., 67, 930–932 (2003).
  • 26) Tietze, F., Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem., 27, 502–522 (1969).
  • 27) Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., and Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J. Immunol., 130, 1910–1917 (1983).
  • 28) Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A.,Yan, S. D., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., and Schmidt, A. M., Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem., 274, 31740–31749 (1999).
  • 29) Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., and Wautier, J. L., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab., 280, E685–E694 (2001).
  • 30) Nagai, R., Matsumoto, K., Ling, X., Suzuki, H., Araki, T., and Horiuchi, S., Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes, 49, 1714–1723 (2000).
  • 31) Nagai, R., Hayashi, C. M., Xia, L., Takeya, M., and Horiuchi, S., Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J. Biol. Chem., 277, 48905–48912 (2002).
  • 32) Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., and Horiuchi, S., Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem., 230, 408–415 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.